4 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
By phase and status
Follow drozitumab: new trials by email Literature Review of drozitumab trials Research Report on drozitumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g) bevacizumab, FOLFOX, PRO95780 - Metastatic Colorectal Cancer | Phase 1 | Completed | 9 | 2009-05-01 | 2022-12-13 |
A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g) PRO95780, rituximab - Non-Hodgkin's Lymphoma | Phase 2 | Completed | 49 | 2008-03-01 | 2017-06-06 |
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) bevacizumab, cetuximab, FOLFIRI regimen - Colorectal Cancer | Phase 1 | Completed | 20 | 2007-10-01 | 2017-05-19 |
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) bevacizumab, carboplatin, paclitaxel - Non-Small Cell Lung Cancer | Phase 2 | Completed | 128 | 2007-06-01 | 2017-05-18 |
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g) PRO95780 - Chondrosarcoma | Phase 2 | Terminated | 15 | 2007-05-31 | 2022-12-13 |
Conditions studied
Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Chondrosarcoma (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Sponsors
Genentech, Inc. (5)
Countries
Australia (1) · United States (1)
Top investigators
Gordon Bray, M.D. (3) · Chia Portera, M.D. (1) · Sandra Skettino, M.D. (1)